Maintenance therapies in bipolar disorders

Michael Gitlin, Mark A Frye

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Objective: Bipolar disorder is an inherently recurrent disorder, requiring maintenance preventive treatments in the vast majority of patients. The authors review the data on maintenance treatments in bipolar disorder, highlighting the controlled trial literature. Methods: Literature review using PubMed, Medline, and a hand search of relevant literature. Results: Over the last decade, a number of effective maintenance treatments for bipolar disorder have been developed with an evidence base for second-generation antipsychotics and some anticonvulsants. Increasing numbers of patients, therefore, are appropriately treated with multiple medications as a maintenance regimen. For some medications, maintenance treatment has been demonstrated in randomized controlled trials for both monotherapy and in combination with other mood stabilizers. Lithium continues as our oldest well-established maintenance treatment in bipolar disorder with somewhat better efficacy in preventing mania than depression. Lamotrigine, olanzapine, and quetiapine have bimodal efficacy in preventing both mania and depression, although lamotrigine's efficacy is more robust in preventing depression and olanzapine's efficacy is greater in preventing mania. Aripiprazole, ziprasidone, and risperidone long-acting injection all prevent mania, but not depression. Less controlled investigations have suggested some evidence of maintenance mood stabilization with carbamazepine, oxcarbazepine, and adjunctive psychotherapy. Conclusions: Despite the number of agents with demonstrated efficacy as maintenance treatments in bipolar disorder, optimal treatment regimens are still a combination of evidence-based therapy in combination with individualized creative treatment algorithms.

Original languageEnglish (US)
Pages (from-to)51-65
Number of pages15
JournalBipolar Disorders
Volume14
Issue numberSUPPL.2
DOIs
StatePublished - May 2012

Fingerprint

Bipolar Disorder
olanzapine
Depression
Therapeutics
Maintenance
Risperidone
Carbamazepine
Lithium
PubMed
Psychotherapy
Anticonvulsants
Antipsychotic Agents
Randomized Controlled Trials
Injections

Keywords

  • Anticonvulsants
  • Antipsychotics
  • Bipolar disorder
  • Lithium
  • Maintenance
  • Treatment

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Maintenance therapies in bipolar disorders. / Gitlin, Michael; Frye, Mark A.

In: Bipolar Disorders, Vol. 14, No. SUPPL.2, 05.2012, p. 51-65.

Research output: Contribution to journalArticle

Gitlin, Michael ; Frye, Mark A. / Maintenance therapies in bipolar disorders. In: Bipolar Disorders. 2012 ; Vol. 14, No. SUPPL.2. pp. 51-65.
@article{d6eb9c8a00ad4e2b9d9e890c98e9596a,
title = "Maintenance therapies in bipolar disorders",
abstract = "Objective: Bipolar disorder is an inherently recurrent disorder, requiring maintenance preventive treatments in the vast majority of patients. The authors review the data on maintenance treatments in bipolar disorder, highlighting the controlled trial literature. Methods: Literature review using PubMed, Medline, and a hand search of relevant literature. Results: Over the last decade, a number of effective maintenance treatments for bipolar disorder have been developed with an evidence base for second-generation antipsychotics and some anticonvulsants. Increasing numbers of patients, therefore, are appropriately treated with multiple medications as a maintenance regimen. For some medications, maintenance treatment has been demonstrated in randomized controlled trials for both monotherapy and in combination with other mood stabilizers. Lithium continues as our oldest well-established maintenance treatment in bipolar disorder with somewhat better efficacy in preventing mania than depression. Lamotrigine, olanzapine, and quetiapine have bimodal efficacy in preventing both mania and depression, although lamotrigine's efficacy is more robust in preventing depression and olanzapine's efficacy is greater in preventing mania. Aripiprazole, ziprasidone, and risperidone long-acting injection all prevent mania, but not depression. Less controlled investigations have suggested some evidence of maintenance mood stabilization with carbamazepine, oxcarbazepine, and adjunctive psychotherapy. Conclusions: Despite the number of agents with demonstrated efficacy as maintenance treatments in bipolar disorder, optimal treatment regimens are still a combination of evidence-based therapy in combination with individualized creative treatment algorithms.",
keywords = "Anticonvulsants, Antipsychotics, Bipolar disorder, Lithium, Maintenance, Treatment",
author = "Michael Gitlin and Frye, {Mark A}",
year = "2012",
month = "5",
doi = "10.1111/j.1399-5618.2012.00992.x",
language = "English (US)",
volume = "14",
pages = "51--65",
journal = "Bipolar Disorders",
issn = "1398-5647",
publisher = "Blackwell Munksgaard",
number = "SUPPL.2",

}

TY - JOUR

T1 - Maintenance therapies in bipolar disorders

AU - Gitlin, Michael

AU - Frye, Mark A

PY - 2012/5

Y1 - 2012/5

N2 - Objective: Bipolar disorder is an inherently recurrent disorder, requiring maintenance preventive treatments in the vast majority of patients. The authors review the data on maintenance treatments in bipolar disorder, highlighting the controlled trial literature. Methods: Literature review using PubMed, Medline, and a hand search of relevant literature. Results: Over the last decade, a number of effective maintenance treatments for bipolar disorder have been developed with an evidence base for second-generation antipsychotics and some anticonvulsants. Increasing numbers of patients, therefore, are appropriately treated with multiple medications as a maintenance regimen. For some medications, maintenance treatment has been demonstrated in randomized controlled trials for both monotherapy and in combination with other mood stabilizers. Lithium continues as our oldest well-established maintenance treatment in bipolar disorder with somewhat better efficacy in preventing mania than depression. Lamotrigine, olanzapine, and quetiapine have bimodal efficacy in preventing both mania and depression, although lamotrigine's efficacy is more robust in preventing depression and olanzapine's efficacy is greater in preventing mania. Aripiprazole, ziprasidone, and risperidone long-acting injection all prevent mania, but not depression. Less controlled investigations have suggested some evidence of maintenance mood stabilization with carbamazepine, oxcarbazepine, and adjunctive psychotherapy. Conclusions: Despite the number of agents with demonstrated efficacy as maintenance treatments in bipolar disorder, optimal treatment regimens are still a combination of evidence-based therapy in combination with individualized creative treatment algorithms.

AB - Objective: Bipolar disorder is an inherently recurrent disorder, requiring maintenance preventive treatments in the vast majority of patients. The authors review the data on maintenance treatments in bipolar disorder, highlighting the controlled trial literature. Methods: Literature review using PubMed, Medline, and a hand search of relevant literature. Results: Over the last decade, a number of effective maintenance treatments for bipolar disorder have been developed with an evidence base for second-generation antipsychotics and some anticonvulsants. Increasing numbers of patients, therefore, are appropriately treated with multiple medications as a maintenance regimen. For some medications, maintenance treatment has been demonstrated in randomized controlled trials for both monotherapy and in combination with other mood stabilizers. Lithium continues as our oldest well-established maintenance treatment in bipolar disorder with somewhat better efficacy in preventing mania than depression. Lamotrigine, olanzapine, and quetiapine have bimodal efficacy in preventing both mania and depression, although lamotrigine's efficacy is more robust in preventing depression and olanzapine's efficacy is greater in preventing mania. Aripiprazole, ziprasidone, and risperidone long-acting injection all prevent mania, but not depression. Less controlled investigations have suggested some evidence of maintenance mood stabilization with carbamazepine, oxcarbazepine, and adjunctive psychotherapy. Conclusions: Despite the number of agents with demonstrated efficacy as maintenance treatments in bipolar disorder, optimal treatment regimens are still a combination of evidence-based therapy in combination with individualized creative treatment algorithms.

KW - Anticonvulsants

KW - Antipsychotics

KW - Bipolar disorder

KW - Lithium

KW - Maintenance

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84859851346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859851346&partnerID=8YFLogxK

U2 - 10.1111/j.1399-5618.2012.00992.x

DO - 10.1111/j.1399-5618.2012.00992.x

M3 - Article

C2 - 22510036

AN - SCOPUS:84859851346

VL - 14

SP - 51

EP - 65

JO - Bipolar Disorders

JF - Bipolar Disorders

SN - 1398-5647

IS - SUPPL.2

ER -